Lyngby, Denmark

Dorte Kirstein


Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1992-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dorte Kirstein

Introduction

Dorte Kirstein, an accomplished inventor based in Lyngby, Denmark, has made significant strides in the field of pharmaceutical innovation. With a total of three patents to her name, Kirstein has focused her research on advancements that contribute to medical science and improve treatment options for various conditions.

Latest Patents

Among her notable contributions, Kirstein's latest patents include:

1. Quinoline derivatives containing a diol as leukotriene antagonists.

2. Isoserine derivatives and their use as leukotriene antagonists.

These inventions highlight her commitment to addressing critical medical challenges and enhancing therapeutic approaches through innovative chemical compounds.

Career Highlights

Throughout her career, Dorte Kirstein has worked with prestigious organizations, including Leo Pharmaceutical Products, Ltd., and Leo Pharmaceutical Products A/S. Her experience in these companies has allowed her to refine her expertise in drug development and research, ultimately leading to her successful patent applications.

Collaborations

Kirstein has collaborated with other talented professionals in her field, including Schneur Rachlin and Ian Ahnfelt-Ronne. Working alongside such individuals has enriched her research and facilitated the exchange of valuable ideas that drive innovation in pharmaceutical science.

Conclusion

Dorte Kirstein's dedication to her work and her impressive portfolio of patents underscore her role as a pivotal figure in the realm of pharmaceuticals. With a focus on leukotriene antagonists, her contributions are expected to influence ongoing research and inspire future innovations in medical treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…